Issue 3 2024
-
Highlights for Sunday, April 7: Opening Ceremony, Clinical Trials Plenary, and more
Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview notable items on Sunday’s schedule to help you plan your day.
-
AACR-ASCO joint session to explore latest strategies for detection, treatment of minimal residual disease
American Society of Clinical Oncology (ASCO) President Lynn M. Schuchter, MD, and AACR President Philip D. Greenberg, MD, FAACR, will chair a special session on strategies for detecting minimal residual disease and how to apply it in the clinic.
-
Meet-the-expert sessions offer opportunity to engage with thought leaders from around the world
Annual Meeting attendees will have the chance to hear individual presentations from Lillian L. Siu, MD, FAACR; Jennifer Rubin Grandis, MD, FAACR; Sangeeta N. Bhatia, MD, PhD, FAACR; Kenneth C. Anderson, MD, FAACR; and Gerrit A. Meijer, MD, PhD.
-
AACR, Japanese Cancer Association to host joint session on evolving landscape of gastroesophageal cancers
Tatsuhiro Shibata, MD, PhD, and Elena Elimova, MD, MSc, will chair a special session featuring an international panel of experts discussing novel molecular drivers of gastroesophageal cancers and evolving biomarker driven therapies.
-
Panel to explore new and emerging advances in cancer neuroscience
Moran Amit, MD, PhD, will chair a Sunday symposium on how the nervous system regulates cancer and how cancer neuroimmunology may transform clinical oncology.
-
Session will explore latest research addressing inflammatory breast cancer
Massimo Cristofanilli, MD, will chair a Sunday afternoon panel discussion on recent research into diagnostic and treatment strategies for inflammatory breast cancer.